In breast cancer cells MDA-MB-231, AU565 and T47D, a knockout TRPM7, reduced cell growth and the use of 2-aminoethoxydiphenyl borate (2-APB), an inhibitor of TRP channel activity, demonstrates a cell cycle alteration. Here, TRPM7 is linked to breast cancer.